PPT-Management of NRTI Resistance
Author : giovanna-bartolotta | Published Date : 2017-09-09
David Spach MD Principal Investigator NW AETC Professor of Medicine Division of Infectious Diseases University of Washington Last Updated June 8 2015 NRTI Resistance
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Management of NRTI Resistance" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Management of NRTI Resistance: Transcript
David Spach MD Principal Investigator NW AETC Professor of Medicine Division of Infectious Diseases University of Washington Last Updated June 8 2015 NRTI Resistance Outline Mechanism of NRTI Resistance. Jim Demarest. ,. 1. Mark Underwood,. 2. Marty St Clair,. 2. . David Dorey,. 3. Steve Almond,. 3. Robert Cuffe,. 4. . Dannae Brown,. 5. Garrett Nichols. 6. . 1. ViiV Healthcare, Global R&D, Research Triangle Park, NC, USA; . Chapter 07. Benefits of Resistance Training. Resistance training is a systematic program of exercise for development of the muscular system for clients of various ages and interests:. Strength. Endurance. AP Physics C. Internal Resistance. All components in a circuit off some type of resistance regardless of how large or small it is. Batteries especially have what is called an . internal resistance. , . % . survivors. Penicillin. Untreated. Days. Penicillin increased the chance of survival from 10% to 90%. Patients with. pneumonia . and bacteria . in the blood. Adapted from Austrian . et al.. Ann. Int. Med 1964; . FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . Design. Objective. Non inferiority of DTG at W48: % HIV RNA < 50 c/mL by intention to treat, snapshot analysis (1-sided significance level of 2.5%, lower margin of the 95% CI for the difference = -12%, 90% power). TKI. s. . and . related. . treatment . strategies. Rafal . Dziadziuszko. Medical. . University. of Gdańsk, Poland. 16th European . Congress. „. Perspectives. in . Lung. Cancer. ” . Torino. What IS Resistance?. On what will resistance depend?. Electrical Resistance. A measure of how easily charge flows through a material. A . Resistor. is a material of significant resistance that has been placed in an electric circuit in order to control current or voltage. EFV vs LPV/r vs EFV + LPV/r . A5142. Mexican. . Study. NVP vs ATV/r . ARTEN . EFV vs ATV/r . A5202. DOR vs DRV/r. DRIVE-FORWARD. Design. Objective. Non inferiority of DOR at W48: % HIV RNA < 50 c/mL by intention to treat, . Camille Angle, Meagan Bardan, Hanna Schimjawicz and Sean Tabarah. PHM142 Fall . 2018. Instructor: . Ms. Maya Latif. Coordinator: Dr. J. Henderson. HIV Attachment and Penetration. Wilen, C. B., Tilton, J. C., & Doms, R. W. D. (2012). HIV: Cell binding and entry. . ATV/r 300/100 mg QD 3TC 300 mg QD. N = 133. N = 133. Continuación ATV/r 300/100 mg QD 2 NRTI . Diseño. Randomización. 1:1. Etiqueta abierta. Objetivo. Endpoint. primario: proporción de pacientes sin fallo al tratamiento a S48 . Clinical Pharmacist – HIV Medicine. Outline. What is HIV?. Common Labs. Life Cycle and Medication Targets. Building an HIV regimen. HIV Guidelines. When to start treatment. What medications to start. Dr. Ashirbachan Mahapatra. Assistant . Professor. Department of Agronomy and Agroforestry. MSSSoA. , CUTM. Lecture . 12. Herbicide Resistance: . Naturally . occurring inheritable ability of some weed biotypes within a population to survive a herbicide treatment that would, under conditions of . TOTEM. Switching the NRTI Backbone to Tenofovir DF-Emtricitabine. TOTEM: Study Design. Source. : . Valantin. MA, et al. . J . Antimicrob. . Chemother. . 2010;65:556-61.. TDF-FTC + Continue . 3. rd. Supported by an educational grant from Gilead Sciences, Inc.. Gregory D. . Huhn. , MD, MPHTM. COVID-19 Vaccination Coordinator and Senior Director of HIV Services. Cook County Health. Associate Professor, Department of Internal Medicine, Division of Infectious Disease.
Download Document
Here is the link to download the presentation.
"Management of NRTI Resistance"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents